We’ve looked at a few “takeover target” pitches from Dylan Jovine in recent years — about a year ago the pitch was for Iovance Biotherapeutics (IOVA), and that didn’t go anywhere (the stock is now down about 50%), and before that the inaugural teaser pick from this service was Denali Therapeutics (DNLI) in early 2020, […]
↧